Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence John

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of HIV Therapy|December 25, 2010
A review of the use of activation markers in AfricaLaurence John, Fred Lutwama
HIV Medicine|May 14, 2004
Primary prophylaxis for cryptococcal meningitisLaurence John, Mark Nelson
AIDS (London, England)|May 16, 2007
When to switch for antiretroviral treatment failure in resource-limited settings?Marc Vekemans, Laurence John, Robert Colebunders
Current Drug Targets|April 7, 2011
How to manage the risk of colorectal cancer in ulcerative colitisRaja Affendi Raja Ali, Laurence John Egan
International Journal of Surgery Case Reports|January 2, 2018
Open splenectomy for Varicella zoster induced spontaneous splenic ruptureMark Christopher Sykes, Bilal Azhar, Laurence John, et al.
Chembiochem : a European Journal of Chemical Biology|May 21, 2025
Designing the Proteome with Chemical Tools: Degrons and BeyondLaurence John Seabrook, Catherine Ramirez Livelo, Lauren Veronica Albrecht
The Journal of Infection|October 4, 2015
Whole spine imaging is justified in tuberculous spondylodiscitis but not pyogenic spondylodiscitisAula Abbara, Ann Tivey, Laurence John, et al.
European Journal of Gastroenterology & Hepatology|February 2, 2012
Diagnosis and treatment strategies of tuberculous intestinal perforations: a case seriesMing J Lee, Fiona V Cresswell, Laurence John, et al.
Inflammatory Bowel Diseases|January 13, 2015
Effect of genetic deletion or pharmacological antagonism of tumor necrosis factor alpha on colitis-associated carcinogenesis in miceBrian Craven, Violeta Zaric, Abigail Martin, et al.
Lancet (London, England)|January 21, 2014
Reversing the tide of the UK tuberculosis epidemicNikita Shah, Sarah Young, Rohma Ghani, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of HIV Therapy|December 25, 2010
A review of the use of activation markers in AfricaLaurence John, Fred Lutwama
HIV Medicine|May 14, 2004
Primary prophylaxis for cryptococcal meningitisLaurence John, Mark Nelson
AIDS (London, England)|May 16, 2007
When to switch for antiretroviral treatment failure in resource-limited settings?Marc Vekemans, Laurence John, Robert Colebunders
Current Drug Targets|April 7, 2011
How to manage the risk of colorectal cancer in ulcerative colitisRaja Affendi Raja Ali, Laurence John Egan
International Journal of Surgery Case Reports|January 2, 2018
Open splenectomy for Varicella zoster induced spontaneous splenic ruptureMark Christopher Sykes, Bilal Azhar, Laurence John, et al.
Chembiochem : a European Journal of Chemical Biology|May 21, 2025
Designing the Proteome with Chemical Tools: Degrons and BeyondLaurence John Seabrook, Catherine Ramirez Livelo, Lauren Veronica Albrecht
The Journal of Infection|October 4, 2015
Whole spine imaging is justified in tuberculous spondylodiscitis but not pyogenic spondylodiscitisAula Abbara, Ann Tivey, Laurence John, et al.
European Journal of Gastroenterology & Hepatology|February 2, 2012
Diagnosis and treatment strategies of tuberculous intestinal perforations: a case seriesMing J Lee, Fiona V Cresswell, Laurence John, et al.
Inflammatory Bowel Diseases|January 13, 2015
Effect of genetic deletion or pharmacological antagonism of tumor necrosis factor alpha on colitis-associated carcinogenesis in miceBrian Craven, Violeta Zaric, Abigail Martin, et al.
Lancet (London, England)|January 21, 2014
Reversing the tide of the UK tuberculosis epidemicNikita Shah, Sarah Young, Rohma Ghani, et al.
Pageof 5